KLK3 and neoplasm: Biochemical recurrence (BCR) is defined as an increase in serum prostate-specific antigen (PSA) concentration after prostatectomy or radiation therapy without grossly visible recurrent lesions with conventional imaging2, indicating possible tumor recurrence3.